Updated:
Andera Partners
Andera Partners is a Paris-based asset management firm established in 2001.
Andera Partners
Andera Partners is a Paris-based asset management firm established in 2001. It focuses on growth, buyout, and life sciences investments, with a sector focus on agribusiness.
General information
Firm type
Generalist
Year founded
2001
AUM
Above €4B (per Les Echos, 2024)
Location
Region
Europe
Country
France
City
Paris
Corporate office
Paris, France
Additional offices
Munich, Germany · Milan, Italy · Antwerp, Belgium
Principals
Philippe Ouaki
Managing Partner, Life Sciences
Raphaël Wisniewski
Managing Partner, Growth & Buyout
Pierre Devillard
Managing Partner, Growth & Buyout
Sector focus
Frequently asked questions
Who runs investment decisions at Andera Partners?
Philippe Ouaki leads the life sciences practice, while Raphaël Wisniewski and Pierre Devillard co-head the growth and buyout activities. The firm operates as a partnership with investment committees composed of managing partners. Sector-specific teams have autonomous decision-making authority within fund mandates.
How is Andera Partners related to AG2R La Mondiale?
Andera began in 2001 as the in-house private-equity group of French insurer AG2R La Mondiale. The management team executed a buyout in 2012, becoming an independent partnership. AG2R La Mondiale remains a limited partner in certain funds but holds no ownership stake in the management company.
Does Andera invest only in France?
No. While France represents the firm's largest market, Andera actively invests across continental Europe. Its growth and buyout practice covers DACH and Benelux through offices in Munich, Antwerp and Milan. The life sciences strategy has backed companies in Belgium, the Netherlands and Switzerland.
What is Andera's typical equity check size?
The Winch buyout funds typically write equity tickets of €15 million to €50 million. The Acto growth funds target smaller minority and growth-equity investments. The life sciences team participates in venture rounds from seed to crossover, with initial checks ranging from €2 million to €20 million.
Does Andera Partners co-invest alongside its limited partners?
Yes. Several of Andera's French corporate limited partners co-invest directly in deals alongside firm funds, particularly in carve-outs and joint ventures. The firm formalizes co-investment rights in its limited-partnership agreements and structures deals to accommodate direct corporate participation.
Does Andera raise stand-alone life sciences funds?
Yes. The firm has raised multiple dedicated life sciences vehicles under the Andera Life Sciences banner, focusing on biotech, medtech and digital health. In 2022, it announced a €274 million close for its latest life sciences fund, targeting therapeutics and diagnostics companies across Europe (per Endpoints News, 2022).
How deep are Andera's corporate relationships in France?
Approximately two dozen CAC 40 companies invest as limited partners across Andera's fund families, according to public record. These relationships provide preferential deal flow and commercial pilot opportunities for portfolio companies. The firm considers this corporate network a moat in French mid-market private equity.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: